Vietnamese scientists will test the effectiveness and safety of using HIV/AIDS medication to treat those infected with the novel coronavirus (COVID-19).
Vietnamese scientists are studying treatment for COVID-19 infected patients (Photo: vietnamnet.vn)
Hanoi (VNS/VNA) - Vietnamese scientists willtest the effectiveness and safety of using HIV/AIDS medication to treat thoseinfected with the novel coronavirus (COVID-19).
The scientific project approved earlier this week by Minister of Science and Technology Chu NgocAnh under the recommendation of the Ministry of Health will test the drugslopinavir and ritonavir.
The project will be carried out by the National Hospital ofTropical Diseases, Ho Chi Minh City’s Hospital of Tropical Diseases, HCM CityPasteur Institute, the National Institute of Hygiene and Epidemiology, and thePharmacovigilance Centre.
Lopinavir and ritonavir are antiretroviral drugs used asmedication to treat HIV/AIDS.
The scientists will evaluate the clinical and sub-clinicaleffectiveness, virological response and safety of lopinavir and ritonavircombination treatment for COVID-19 infected patients based on the HealthMinistry’s background treatment regimen.
The evaluation would be completed within 12 months.
Earlier this month, the Ministry of Science and Technologyalso approved a list of three urgent tasks for preventing the coronavirus fromspreading.
The tasks included manufacturing three kinds of test kits ofclassifying and diagnosing COVID-19 infections within a month.
The Military Medical University and Viet A Technology StockCompany were assigned to study and manufacture test kits to detect the virus.
Researching and producing a rapid detection system to screenfor COVID-19 was carried out by Phu Sa Biochemistry Company, HCM City’s PasteurInstitute, and Can Tho city’s Scientific and Technological Application Centre.
The HCM City’s Pasteur Institute was designated to studyepidemiological and clinical characteristics of the COVID-19 caused acuterespiratory infections in Vietnam./.
Three patients from the northern province of Vinh Phuc infected with the novel coronavirus (2019-nCoV) have recovered and were discharged from the National Hospital of Tropical Diseases (NHTD) in Hanoi on February 10.
Deputy Prime Minister Vu Duc Dam on February 12 said supervision and quarantine work is the most important work at present to curb the spread of the novel coronavirus (Covid-19).
The Health Ministry reported on February 13 that it has sent materials and a permanent working team to the northern province of Vinh Phuc to help with the fight against the acute respiratory disease caused by the new coronavirus (COVID-19).
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Vietnamese scientists are studying treatment for COVID-19 infected patients (Photo: vietnamnet.vn) 
